Latest news
How large pharma impacts biotechnology startup success – Nature Biotechnology
BGV's Daniela Couto and Gina Melcher von Dydiowa together with Sander van Deventer of Forbion published an article in Nature Biotechnology on pharma involvement in biotech startup success. Click on this link to read the whole article. Abstract: Many novel therapeutic...
Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman
Philippe Dro brings entrepreneurial expertise and biotech, medtech and pharma industry experience Successful serial entrepreneur with track record of growing companies, notably for Themis and Glycovaxyn Joins at a key juncture in Scenic Biotech’s strategic growth,...
CatalYm Starts First-in-Human Phase I Clinical Trial with GDF-15 Neutralizing Antibody CTL-002 to Treat Patients with Checkpoint-Inhibitor Refractory Cancer
Munich, Germany, January 28, 2021 — CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, announced today the start of clinical development of CTL-002, its proprietary GDF-15 neutralizing antibody designed to enhance effector T cell entry...
VarmX appoints Dr. Gerard Short as Chief Medical Officer
Leiden, The Netherlands, 27 January 2021 - VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the appointment of Dr. Gerard Short, MBBS, as Chief Medical Officer (CMO). As CMO, Dr. Short...
Next events
LSX World Congress, February 1-5, 2021
www.lsxleaders.com/
BIO-Europe Spring, March 22-25, 2021
https://informaconnect.com/bioeurope-spring/